Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferators.
D000502:Allylisopropylacetamide / Q000494:pharmacology; D000640:Amitrole / Q000494:pharmacology; D000818:Animals; D002332:Carnitine O-Acetyltransferase / Q000378:metabolism; D002374:Catalase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002992:Clofenapate / Q000494:pharmacology; D002994:Clofibrate / Q000494:pharmacology; D008055:Lipids / Q000097:blood*; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D008297:Male; D008830:Microbodies / Q000201:enzymology; D008854:Microscopy, Electron; D009255:Nafenopin / Q000494:pharmacology; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011916:Rats, Inbred F344
D008055:Lipids; D009255:Nafenopin; D002992:Clofenapate; D000502:Allylisopropylacetamide; D002374:Catalase; D002332:Carnitine O-Acetyltransferase; D002994:Clofibrate; D000640:Amitrole